[1] Juhasz C, Chugani DC, Muzik O, et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy[J]. Neurology, 2000, 55(6): 825-835.
[2] Hammers A, Koepp MJ, Hurlemann R, et al. Abnormalities of grey and white matter[11C] flumazenil binding in temporal lobe epilepsy with normal MRI[J]. Brain, 2002, 125(10): 2257-2271.
[3] Juhasz C, Muzik O, Chugani DC, et al. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy[J]. Epilepsia,2001, 42(10): 1320-1326.
[4] 邱炳辉.PET显像与癫痫灶定位[J].国外医学·神经病学神经外科学分册,2000,27(6): 323-327.
[5] Duncan JS. Positron emission tomography receptor studies[J]. Adv Neurol, 1999, 79: 893-899.
[6] Kumlien E, Hartvig P, Valind S,et al. NMDA-receptor activity visualized with (S)-[N-methyl-11C] ketamine and positron emission tomography in patients with medial temporal lobe epilepsy[J]. Epilepsia, 1999, 40(1): 30-37.
[7] Pennell PB. PET: cholinergic neuroreceptor mapping[J].Adv Neurol, 2000, 83: 157-163.
[8] Dupont S, Semah F, Loćh C, et al. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br] 4-bromodexetimide[J]. J Nucl Med, 1999, 40(6): 935-941.
[9] Bonati MT, Combi R, Asseha R, et al. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families[J]. J Neurol,2002, 249(8): 967-974.
[10] Kumlien E, Nilason A, Hagberg G, et al. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy[J]. Acta Neural Stand, 2001, 103(6): 360-366.
[11] Fedi M, Reutens D, Okazawa H,et al. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin[J]. Neurology, 2001, 57(9): 1629-1636.
[12] Chugani DC, Chugani HT, Muzik O, et al. Imaging epilepto-genic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography[J]. Ann Neurol, 1998,44(6): 858-866.